Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples